Main nosologies for cell therapy

Clinical Applications of Regenerative and Cellular Technologies

Cell therapy has become a key component of modern medical practice, providing clinicians with new biological tools to restore or support organ function, regulate immune responses, and repair structural damage at the cellular level.
At AMS Asia, we coordinate international access to evidence-based cell therapy programs implemented in accredited biotechnology and clinical research centers across Asia, Europe, and the Middle East.
Our objective is to ensure that each patient receives a verified, safe, and individually designed treatment protocol, built on clinical data and international standards.

Definition and Mechanism

Cell therapy involves the use of autologous or allogeneic cells — primarily mesenchymal stem cells (MSCs), hematopoietic cells, or immune effectors — to replace or regenerate damaged tissue and normalize biological functions.
These cells act through multiple mechanisms:• Regulation of inflammation and immune activity• Activation of endogenous repair processes• Support of angiogenesis and tissue remodeling• Secretion of growth factors and anti-inflammatory mediators• Modulation of metabolic and oxidative pathways

All therapeutic protocols coordinated by AMS Asia are based on preclinical and clinical research data that meet international safety and efficacy criteria.

Main Clinical Directions

1. Neurology and Neurodegeneration• Applications include supportive therapy for:• Stroke and post-stroke rehabilitation• Parkinson’s disease and Alzheimer’s disease• Multiple sclerosis• Traumatic brain or spinal cord injury• Peripheral neuropathies
Cell-based interventions may improve neuronal survival, reduce neuroinflammation, and support synaptic recovery.
2. Orthopedic and Musculoskeletal DisordersIndications include:• Osteoarthritis and cartilage degeneration• Tendon and ligament injuries• Post-traumatic and post-surgical recovery• Chronic back pain and degenerative disc disease
Cellular therapy is used to stimulate tissue regeneration, reduce inflammation, and enhance functional outcomes.
3. Cardiovascular and Metabolic DiseasesTargeted use in:• Ischemic heart disease• Heart failure• Peripheral vascular disorders• Diabetic microangiopathy and metabolic imbalance
Stem and progenitor cells contribute to vascular regeneration and improved myocardial perfusion.
4. Autoimmune and Inflammatory ConditionsRegenerative immunomodulation supports management of:• Rheumatoid arthritis• Systemic lupus erythematosus• Inflammatory bowel disease (Crohn’s, ulcerative colitis)• Psoriasis and autoimmune thyroiditis
Therapeutic cells act by reducing chronic inflammation and restoring immune homeostasis.
5. Endocrine and Reproductive DisordersClinical use includes:• Type 1 and Type 2 diabetes mellitus• Premature ovarian insufficiency and infertility• Androgen deficiency and erectile dysfunction• Thyroid and adrenal insufficiency
Cellular therapies aim to stabilize endocrine function and enhance metabolic regulation.
6. Hepatic, Renal, and Pulmonary PathologiesSupportive applications in:• Chronic liver diseases, including cirrhosis and hepatitis• Chronic kidney disease• Pulmonary fibrosis and chronic obstructive pulmonary disease
Regenerative interventions improve tissue oxygenation, reduce fibrotic processes, and help preserve organ function.
7. Oncology-Related and Post-Treatment Support• Cell therapy may be used as an adjunct in oncology for:• Restoration of hematopoiesis after chemotherapy or radiation• Reduction of systemic inflammation and fatigue• Modulation of immune tolerance• Recovery of tissue integrity following oncologic interventions
In selected cases, integration with immune cell therapy (NK, T, DC vaccines) and oncolytic virotherapy is possible under clinical supervision.

Implementation and Coordination

AMS Asia facilitates the integration of regenerative medicine into multidisciplinary treatment pathways.
Each program includes:• Comprehensive medical evaluation and diagnostics• Review of clinical indications and safety parameters• Coordination with certified regenerative centers• Organization of travel, accommodation, and translation support• Continuous post-treatment monitoring and reporting
All procedures comply with bioethical frameworks, international regulatory norms, and current Good Clinical Practice (GCP) standards.